Clinical Protocol  
Id: Test Protocol ALL 
Status: Unapproved 
Last Modified: April 12 2019 14:33:21:767 
Diagnosis: Sick 
Treatment Site: NOSE - nose 
Description: A test protocol that has everything 

--------------------------------------------------------------------------------

Protocol Summary
Plan Summary
Plan Id Field Count Default Treament Unit Default Energy Mode Primary Fraction Dose [cGy] Fraction Count 
LUNL Plan 2 TR1 6 Photon 200.0 30 

Plan Primary Objectives Summary
Plan Id Primary Prescription Prescription Fraction Dose [cGy] Fraction Count Total Dose [cGy] 
LUNL Plan  PTV Minimum dose is more than 200.0 30 6000.0 

Protocol Structure Summary
Id Type Color and Style 
PTV PTV z PTV 
Aorta Avoidance Segment - Yellow 

Plan Dose Optimization Objectives Summary
Plan Id Structure Id Type Limit Volume [%] Total Dose [cGy] Priority 
LUNL Plan PTV Point lower 90.00 6000.0 100 
LUNL Plan PTV Point upper 100.00 6600.0 70 
LUNL Plan PTV gEUD upper  0.0 100 
LUNL Plan Aorta Point upper 50.00 1000.0 50 
LUNL Plan Aorta Mean   5000.0 20 
LUNL Plan Aorta Line upper [100.00, 0] [0.0, 6000.0] 50 



--------------------------------------------------------------------------------

Protocol Details
Protocol Structure Details
ID Name Identification Color CT Low CT High DVH Line Style DVH Line Color DVH Line Width 
PTV PTV C34.9PTVICD-O-2 z PTV -700 -500 Dot  5 
Aorta Aorta Avoidance Segment - Yellow 0 200 Dash Automatic 9 

Protocol Plan Details
Plan: LUNL Plan
Plan Mode: Photon Default Treatment Unit: TR1 
Default Energy: 6 Treatment Style: Dynamic ARC 
Fraction Count: 30 Fractions Per Day:  
Fractions Per Week:  
Immobilization Device: Nail Localization Technique: Sonar 
Field Alignment Rules:  

Plan Objective Details
Primary Prescription Fraction Dose [cGy] Total Dose [cGy] 
 PTV At least 90 % receives more than 200.0 6000.0 
 PTV Minimum dose is more than 200.0 6000.0 
 Aorta At most 50 % receives more than 135.9 4076.9 

Plan Measure Details
Structure Measure Criterion Target Value 
PTV Conformity Index is more than 1.00 
PTV Gradient Measure [cm] is less than 2.00 
Aorta V50.00 [% of volume] is less than 5000.00 
Aorta D99.00 [cGy] is less than 2.00 

Plan Fields Summary
Id Technique Energy Primary Fluence Mode Gantry [deg] Collimator [deg] Couch [deg] MLC/Block Wedge Field Size [cm]  Isocenter 
CW PROS ARC 6X  181.00 30.00 0.00 - - 8.73 x 8.61 Relative 
CCW PROS ARC 6X  179.00 330.00 0.00 - - 8.73 x 8.61 Relative 


Plan Field Details
Field: CW PROS
Treatment Unit: CL21B Using Dynamic MLC:  
Energy: 6X Using Compensator:  
Primary Fluence Mode:  
Technique: ARC DRR Template:  
Dose Rate [MU/min]: 600 SFED [cm]:  
Tolerance Table:  Field Weight: 2.0296  
Skin Flash Margin [cm]:  Boluses:  
Gantry Angle [deg]: 181.00 Gantry Stop Angle [deg]: 179.00 
Gantry Direction: CW Table Angle [deg]: 0.00 
Target Volume: ()  
Collimator Size [cm]: X1:-4.17 X2:4.56 Y1:-4.43 Y2:4.18 
Collimator Angle [deg]: 30.00 Collimator Mode: AsymmetryX&Y 
Field Margin [cm]:  
Relative Isocenter, AIO [cm]: [0.00, 0.00, 0.00]  


Field: CCW PROS
Treatment Unit: CL21B Using Dynamic MLC:  
Energy: 6X Using Compensator:  
Primary Fluence Mode:  
Technique: ARC DRR Template:  
Dose Rate [MU/min]: 600 SFED [cm]:  
Tolerance Table:  Field Weight: 1.90237  
Skin Flash Margin [cm]:  Boluses:  
Gantry Angle [deg]: 179.00 Gantry Stop Angle [deg]: 181.00 
Gantry Direction: CC Table Angle [deg]: 0.00 
Target Volume: ()  
Collimator Size [cm]: X1:-4.56 X2:4.17 Y1:-4.43 Y2:4.18 
Collimator Angle [deg]: 330.00 Collimator Mode: AsymmetryX&Y 
Field Margin [cm]:  
Relative Isocenter, AIO [cm]: [0.00, 0.00, 0.00]  


Plan Optimization Objective Details
IMRT
Default Smoothing X: 40 Default Smoothing Y: 30 
Default Minimize Dose: 0 Default Optimization Type: Beamlet 
Max Iterations: 1000 Max Optimize Time [min]: 100.00 
Default Fixed Jaws:  Interpolate:  
Use Colors:  

Beam Angle Optimization
Initial Field Distribution: Coplanar 
Minimum Number of Fields: 5 
Maximum Number of Fields: 9 
Maximum Elevation Angle for Non-Coplanar Fields: 10 
Maximum Collimator Variation: 10 
Local Geometric Optimization Mode: None 

Normal Tissue Objective
Use: true 
Automatic: true 
Priority: 100 
Distance From Target Border: 1 
Start Dose: 105 
End Dose: 60 
Fall-off: 0.05 

Arc Optimization
Use MU Objective:  
MU Objective Strength: 100 
Minimum MU: 650 
Maximum MU: 800 
Jaw Tracking:  

Structure Objectives
Structure Objective: PTV
Volume Type: PTVC34.9ICD-O-2 Surface Only:  
Resolution [mm]: 3.00 

Objectives
Type Limit Volume [%] Total Dose [cGy] Priority Group 
Point lower 90.00 6000.0 100 0 
Point upper 100.00 6600.0 70 0 
gEUD upper  0.0 100 0 

Structure Objective: Aorta
Volume Type: Avoidance Surface Only:  
Resolution [mm]: 0.00 

Objectives
Type Limit Volume [%] Total Dose [cGy] Priority Group 
Point upper 50.00 1000.0 50 0 
Line upper 100.00 0.0 110 1 
Line upper 75.00 2000.0 110 1 
Line upper 50.00 4000.0 100 1 
Line upper 25.00 5000.0 100 1 
Line upper 0 6000.0 100 1 
Mean   5000.0 20 0 

Protocol Review Details
Show Min:  Show Max:  
Show Mean:  Show Modal:  
Show Median:  Show Std Dev:  
Show NDR:  

DVH Structures
Item Type 
PTV Structure 
=PTV sub Aorta Expr 


--------------------------------------------------------------------------------
